Skip to main content

Table 2 Patients clinical features of LN + pancreatic tumors split by primary site

From: Comparable prevalence of distant metastasis and survival of different primary site for LN + pancreatic tumor

 

Total

Pancreas head

Pancreas body tail

P value

Age group, no. (%)

   

0.293

 18–49

521 (9.1)

434 (8.9)

87 (10.2)

 

 50–59

1412 (24.7)

1215 (24.9)

197 (23.2)

 

 60–69

2074 (36.2)

1778 (36.5)

296 (34.9)

 

   ≥ 70

1719 (30.0)

1450 (29.7)

269 (31.7)

 

Sex, no. (%)

   

0.022

 Male

2973 (51.9)

2563 (52.6)

410 (48.3)

 

 Female

2753 (48.1)

2314 (47.4)

439 (51.7)

 

Race, no. (%)

   

0.104

 White

4710 (82.3)

4032 (82.7)

679 (80.0)

 

 Black

592 (10.3)

488 (10.0)

104 (12.2)

 

 Other

424 (7.4)

357 (7.3)

67 (7.9)

 

Marital status, no. (%)

   

0.310

 Never married

709 (12.4)

603 (12.4)

106 (12.5)

 

 Married

3868 (67.6)

3279 (67.2)

589 (69.4)

 

 Divorced/ widowed

1149 (20.1)

995 (20.4)

154 (18.1)

 

Size, no. (%)

   

 < 0.001

  ≤ 2 cm

716 (12.5)

662 (13.6)

54 (6.4)

 

  ≤ 4 cm

3498 (61.1)

3135 (64.3)

363 (42.8)

 

  > 4 cm

1512 (26.4)

1080 (22.1)

432 (50.9)

 

Differentiation, no. (%)

   

0.551

 Well

477 (8.3)

399 (8.2)

78 (9.2)

 

 Intermediate

2590 (45.2)

2197 (45.0)

393 (46.3)

 

 Poor/undifferentiated

2133 (37.3)

1833 (37.6)

300 (35.3)

 

 Missing

526(9.2)

448(9.2)

78(9.2)

 

Lymph node ratio, no. (%)

 1–25%

3466 (60.5)

2923 (59.9)

543 (64.0)

0.019

 26–50%

1505 (26.3)

1315 (27.0)

190 (22.4)

 

  > 50%

755 (13.2)

639 (13.1)

116 (13.7)

 

Number of malignant mass, no. (%)

   

0.305

 One

5493 (95.9)

4684 (96.0)

809 (95.3)

 

 More than one

233 (4.1)

193 (4.0)

40 (4.7)

 

Distance metastasis, no. (%)

   

 < 0.001

 No

5317 (92.9)

4613 (94.6)

704 (82.9)

 

 Yes

409 (7.1)

264 (5.4)

145 (17.1)

 

Stage, no. (%)

   

 < 0.001

 IIB

4917 (85.8)

4277 (87.7)

640 (75.5)

 

 III

302 (5.3)

258 (5.3)

44 (5.2)

 

 IV

507 (8.9)

342 (7.0)

165 (19.3)